Document/ExhibitDescriptionPagesSize
1: 10-K Annual Report HTML 3.43M
2: EX-3.2 Articles of Incorporation/Organization or Bylaws HTML 221K
6: EX-10.10 Material Contract HTML 130K
7: EX-10.20 Material Contract HTML 145K
8: EX-10.27 Material Contract HTML 62K
9: EX-10.28 Material Contract HTML 140K
10: EX-10.30 Material Contract HTML 569K
11: EX-10.32 Material Contract HTML 38K
3: EX-10.4 Material Contract HTML 62K
4: EX-10.5 Material Contract HTML 142K
5: EX-10.9 Material Contract HTML 42K
12: EX-21.1 Subsidiaries List HTML 71K
13: EX-23.1 Consent of Expert or Counsel HTML 36K
14: EX-24.1 Power of Attorney HTML 38K
15: EX-31.1 Certification -- §302 - SOA'02 HTML 40K
16: EX-31.2 Certification -- §302 - SOA'02 HTML 40K
17: EX-32.1 Certification -- §906 - SOA'02 HTML 36K
18: EX-32.2 Certification -- §906 - SOA'02 HTML 36K
24: R1 Cover HTML 99K
25: R2 Audit Information HTML 41K
26: R3 Consolidated Statements of Income HTML 121K
27: R4 Consolidated Statements of Comprehensive Income HTML 72K
28: R5 Consolidated Statements of Comprehensive Income HTML 43K
(Parenthetical)
29: R6 Consolidated Balance Sheets HTML 149K
30: R7 Consolidated Balance Sheets (Parenthetical) HTML 53K
31: R8 Consolidated Statements of Equity and Redeemable HTML 106K
Equity
32: R9 Consolidated Statements of Cash Flows HTML 117K
33: R10 Description of the Business and Summary of HTML 68K
Significant Accounting Policies
34: R11 Acquisitions HTML 43K
35: R12 Intangible Assets HTML 91K
36: R13 Investments HTML 48K
37: R14 Restructuring and Impairment Charges HTML 46K
38: R15 Derivatives Instruments and Hedging Activities HTML 136K
39: R16 Fair Value Measurements HTML 61K
40: R17 Financing Arrangements HTML 73K
41: R18 Leases HTML 66K
42: R19 Income Taxes HTML 125K
43: R20 Pension and Other Postretirement Benefits HTML 373K
44: R21 Equity HTML 185K
45: R22 Information by Segment and Geographic Region HTML 142K
46: R23 Commitments and Contingencies HTML 42K
47: R24 Supplementary Information HTML 132K
48: R25 Description of the Business and Summary of HTML 107K
Significant Accounting Policies (Policies)
49: R26 Intangible Assets (Tables) HTML 97K
50: R27 Investments (Tables) HTML 44K
51: R28 Restructuring and Impairment Charges (Tables) HTML 41K
52: R29 Derivatives Instruments and Hedging Activities HTML 133K
(Tables)
53: R30 Fair Value Measurements (Tables) HTML 58K
54: R31 Financing Arrangements (Tables) HTML 64K
55: R32 Leases (Tables) HTML 70K
56: R33 Income Taxes (Tables) HTML 124K
57: R34 Pension and Other Postretirement Benefits (Tables) HTML 388K
58: R35 Equity (Tables) HTML 187K
59: R36 Information by Segment and Geographic Region HTML 143K
(Tables)
60: R37 Supplementary Information (Tables) HTML 142K
61: R38 Description of the Business and Summary of HTML 50K
Significant Accounting Policies - Property, Plant
and Equipment and Definite-Lived Intangible Assets
(Details)
62: R39 Description of the Business and Summary of HTML 41K
Significant Accounting Policies - Indefinite-Lived
Intangible Assets and Goodwill (Details)
63: R40 Acquisitions - PureCircle Narrative (Details) HTML 49K
64: R41 Acquisitions - Mannitab Pharma Specialties HTML 45K
(Details)
65: R42 Acquisitions - Amishi (Details) HTML 43K
66: R43 Acquisitions - KaTech (Details) HTML 46K
67: R44 Acquisitions - Verdient (Details) HTML 54K
68: R45 Acquisitions - Pre-Tax Acquisition and Integration HTML 38K
Costs (Details)
69: R46 Intangible Assets - Goodwill (Details) HTML 69K
70: R47 Intangible Assets - Other Intangible Assets HTML 69K
(Details)
71: R48 Intangible Assets - Amortization Expense (Details) HTML 55K
72: R49 Investments - Breakdown of Investments (Details) HTML 44K
73: R50 Investments - Amyris & Argentina Joint Venture HTML 67K
(Details)
74: R51 Restructuring and Impairment Charges - Charges HTML 38K
(Details)
75: R52 Restructuring and Impairment Charges - HTML 44K
Restructuring Charges (Details)
76: R53 Restructuring and Impairment Charges - Impairment HTML 63K
Charges (Details)
77: R54 Restructuring and Impairment Charges - HTML 42K
Employee-related Severance (Details)
78: R55 Derivatives Instruments and Hedging Activities - HTML 54K
Commodity Price Hedging (Details)
79: R56 Derivatives Instruments and Hedging Activities - HTML 48K
Foreign Currency Hedging (Details)
80: R57 Derivatives Instruments and Hedging Activities - HTML 52K
Cash Flow Hedges in AOCI (Details)
81: R58 Derivatives Instruments and Hedging Activities - HTML 93K
Balance Sheet Location (Details)
82: R59 Derivatives Instruments and Hedging Activities - HTML 58K
Cash Flow Hedges (Details)
83: R60 Derivatives Instruments and Hedging Activities - HTML 49K
Gain (Losses) Recognized in Income (Details)
84: R61 Fair Value Measurements (Details) HTML 58K
85: R62 Financing Arrangements - Total Debt Outstanding HTML 37K
(Details)
86: R63 Financing Arrangements - Term Loan Agreement HTML 50K
(Details)
87: R64 Financing Arrangements - Revolving Credit HTML 49K
Agreement (Details)
88: R65 Financing Arrangements - Commercial Paper HTML 55K
(Details)
89: R66 Financing Arrangements - Carrying Value and Fair HTML 78K
Value (Details)
90: R67 Financing Arrangements - Guaranteed Obligations HTML 37K
(Details)
91: R68 Leases - Lease Expense (Details) HTML 44K
92: R69 Leases - Operating Lease Reconciliation (Details) HTML 70K
93: R70 Leases - Additional Information (Details) HTML 50K
94: R71 Income Taxes - Provision for Income Taxes HTML 76K
(Details)
95: R72 Income Taxes - Deferred Taxes (Details) HTML 82K
96: R73 Income Taxes - Operating Loss Carryforwards HTML 54K
(Details)
97: R74 Income Taxes - Tax Credit Carryforward Valuation HTML 48K
Allowance (Details)
98: R75 Income Taxes - Reconciliation of Effective Tax HTML 69K
Rate (Details)
99: R76 Income Taxes - Reconciliation of Effective Tax HTML 61K
Rate Narrative (Details)
100: R77 Income Taxes - Unrecognized Tax Benefits (Details) HTML 47K
101: R78 Income Taxes - Unrecognized Tax Benefits Narrative HTML 52K
(Details)
102: R79 Pension and Other Postretirement Benefits - HTML 88K
Pension Obligation and Funded Status (Details)
103: R80 Pension and Other Postretirement Benefits - HTML 135K
Pension Amounts Recognized (Details)
104: R81 Pension and Other Postretirement Benefits - HTML 65K
Pension Assumptions (Details)
105: R82 Pension and Other Postretirement Benefits - HTML 62K
Pension Plan Asset Weighted Average Asset
Allocation (Details)
106: R83 Pension and Other Postretirement Benefits - HTML 133K
Pension Plan Assets by Category and FV (Details)
107: R84 Pension and Other Postretirement Benefits - HTML 64K
Pension Benefit Payments (Details)
108: R85 Pension and Other Postretirement Benefits - HTML 38K
Defined Contribution Plans (Details)
109: R86 Pension and Other Postretirement Benefits - HTML 61K
Postretirement Funded Status (Details)
110: R87 Pension and Other Postretirement Benefits - HTML 97K
Postretirement Amounts Recognized (Details)
111: R88 Pension and Other Postretirement Benefits - HTML 59K
Postretirement Assumptions and Trends (Details)
112: R89 Pension and Other Postretirement Benefits - HTML 49K
Postretirement Benefit Payments (Details)
113: R90 Pension and Other Postretirement Benefits - HTML 42K
Multiemployer Plans (Details)
114: R91 Equity - Preferred Stock (Details) HTML 45K
115: R92 Equity - Treasury Stock (Details) HTML 52K
116: R93 Equity - Share Activity (Details) HTML 66K
117: R94 Equity - Share-based Payments (Details) HTML 61K
118: R95 Equity - Stock Options (Details) HTML 108K
119: R96 Equity - Restricted Stock Units (Details) HTML 82K
120: R97 Equity - Performance Shares (Details) HTML 89K
121: R98 Equity - Other Share-based Awards under the SIP HTML 52K
(Details)
122: R99 Equity - AOCL (Details) HTML 67K
123: R100 Equity - EPS (Details) HTML 78K
124: R101 Information by Segment and Geographic Region - Net HTML 81K
Sales and Operating Income (Details)
125: R102 Information by Segment and Geographic Region - HTML 53K
Assets (Details)
126: R103 Information by Segment and Geographic Region - HTML 54K
Depreciation, Store Expense and Capital
Expenditures (Details)
127: R104 Information by Segment and Geographic Region - HTML 74K
Sales and Long-lived Assets (Details)
128: R105 Commitments and Contingencies (Details) HTML 59K
129: R106 Supplementary Information - Accounts Receivable, HTML 44K
Net (Details)
130: R107 Supplementary Information - Inventories (Details) HTML 44K
131: R108 Supplementary Information - PP&E (Details) HTML 55K
132: R109 Supplementary Information - Accrued Liabilities HTML 51K
(Details)
133: R110 Supplementary Information - Other Non-Current HTML 49K
Liabilities (Details)
134: R111 Supplementary Information - Supplemental Income HTML 46K
Statements and Cash Flow Information (Details)
135: R112 Supplementary Information - Quarterly Financial HTML 78K
Data (Details)
136: R113 Supplementary Information - Additional Quarterly HTML 54K
Financial Data (Details)
139: XML IDEA XML File -- Filing Summary XML 246K
137: XML XBRL Instance -- ingr-20221231_htm XML 5.14M
138: EXCEL IDEA Workbook of Financial Reports XLSX 253K
20: EX-101.CAL XBRL Calculations -- ingr-20221231_cal XML 317K
21: EX-101.DEF XBRL Definitions -- ingr-20221231_def XML 1.33M
22: EX-101.LAB XBRL Labels -- ingr-20221231_lab XML 2.74M
23: EX-101.PRE XBRL Presentations -- ingr-20221231_pre XML 1.90M
19: EX-101.SCH XBRL Schema -- ingr-20221231 XSD 284K
140: JSON XBRL Instance as JSON Data -- MetaLinks 685± 1.09M
141: ZIP XBRL Zipped Folder -- 0001046257-23-000006-xbrl Zip 1.11M
Congratulations! I am pleased to confirm our offer of employment to join Ingredion Incorporated in the position of Chief Innovation Officer and President
Sweetener Specialties, with an anticipated start date of no later than Thursday, October 1, 2020. You will be based in our Bridgewater, NJ location and report to James Zallie, President & Chief Executive Officer.
Base Salary:
You will receive a base salary at an annual rate of $525,000 USD in installments in accordance with Ingredion’s payroll procedures, which currently provide for semi-monthly payments. Your base salary includes compensation for all time worked, as well as appropriate consideration for Company holidays and other time off. Your base salary will be considered for adjustment as part
of our normal year-end performance management and compensation process. The next salary review date will be February 2021. Your position is grade level O and is exempt.
Short Term Incentive Compensation:
Beginning in 2021 you will be eligible to participate in the Ingredion Annual Incentive Plan (AIP) with a target bonus of 60% of your annual rate of base salary; however, depending on the performance achieved, the actual earned award can vary. You will be provided with detailed information about this plan by the Compensation department in early 2021. To compensate you for a forfeiture of your current employer bonus, for fiscal year 2020, you will receive a full (non pro-rated) target bonus of 60% of your annual rate pf base pay, payable when
2020 bonuses are paid (or would be payable) to other executives.
Long Term Incentive Compensation:
Beginning in the first quarter of 2021, you will be eligible to receive equity-based awards under Ingredion’s Long-Term Incentive Program (“LTIP”). Equity awarded to you will be delivered in a mix of Performance Shares (“PSUs”), Restricted Stock Units (“RSUs”), and Stock
Options. Last year, PSUs were weighted at 50%, RSUs were weighted at 25% and Stock Options were weighted at 25%. The number of shares will be determined on the grant date. Currently, the RSU component will vest after three years’ time, while one third of Stock Options will vest
each anniversary of the grant and will be fully vested after three years. PSUs will be earned over a three-year
period based on plan metrics for the performance cycle. Upon vesting, PSUs are delivered in the form of shares of Ingredion stock, and funding can range from 0 to 200% of the “Target”
number of shares. The value of future awards under the LTIP will be based upon the Company's budget for long-term incentive compensation, your job performance, and the scope of your role and responsibilities.
Special Equity Award
A one-time equity award in RSUs valued at $775,000 USD will be issued to you upon hire. One third of these RSUs will vest each anniversary of the grant and will be fully vested after three years. In the event you voluntarily leave the organization before a vesting date, you will forfeit the outstanding tranches
of the grant.
Retention Bonus:
Ingredion will pay you 2 cash retention bonuses as follows:
•$700,000 USD paid in one lump sum payment in March 2021, less withholding required by law. This will be paid in the second pay period of March 2021.
•$500,000 USD paid in one lump sum payment in March 2022, less withholding required by law. This will be paid in the second pay period of March 2022.
As conditions of
the bonuses, you must be actively employed by Ingredion on the date of the payment. In the event you voluntarily leave the organization before any of the above payout dates, you will not receive the remaining retention bonuses. Additionally, if your employment with the Company terminates for any reason other than a reduction in force within 24 months from the payout date of the first or second bonus, the respective
sums shall be reimbursed to the Company based on the following formula: 1) 100% repayment within one year of payment date and 2) 50% repayment between one and two years after the payment.
Relocation expenses:
You are eligible for relocation benefits per the Ingredion US and Canada Relocation Policy. A full summary of benefits based
on Tier 1 status is attached along with a Repayment Agreement, which must be signed and returned prior to receiving
any benefits under the Policy. Ingredion will cover up to $150,000 in relocation benefits. This amount includes any and all associated tax (federal, state and local). Upon acceptance of the offer, our relocation
management company will assign a relocation specialist to you to conduct a thorough review of the authorized benefits.
Additionally, your relocation benefits will include the following:
•Housing Allowance: up to $4,000 per month net of taxes for 12 months (after up to 90 days temporary housing) and up to $2,000 per month net of taxes for the following 12 months
Executive Perquisites:
•You will
have the choice of I) Company car allowance of $ 15,000 per annum paid through U.S. payroll, or 2) Lease of a Company vehicle.
•You will be eligible for a financial advisory perquisite reimbursement of up to $5,500 and
an annual executive physical.
•You will be eligible to participate in the lngredion Incorporated Supplemental Executive Retirement Plan ("SERP"), subject to its terms. The SERP offers pretax deferrals of up to 20% of your
salary and up to 75% of your bonus, and it restores savings and employer matching contributions which would otherwise be lost due to IRS limits.
•The Company will pay your reasonable professional expenses incurred to negotiate and prepare this agreement and all agreements referenced herein in an amount not exceeding $10,000.
•The company will indemnify and hold you harmless (including attorney fees) in the unlikely event that DSM would challenge your ability to join the company under the restrictive covenants with
DSM.
Vacation and floating holidays:
You are eligible to accrue 4 weeks of vacation annually. Employees begin accruing vacation
at the rate of one-twelfth (1/12) of their annual vacation eligibility for each completed calendar month of service after their date of hire. Please note, unless hired on the first calendar day of
the month, you will not earn any vacation during the month you were hired.
In addition, Ingredion grants two (2) floating holidays annually to full-time employees. Employees hired on or before October 1 will be granted the full complement of two
(2) floating holidays as of their date of hire. Employees hired after October 1 will be granted one (1) floating holiday in the year in which they are hired and will receive the full complement of 2 floating holidays on January 1st following your hire date.
Stock Ownership Requirements
•You will be subject to a stock ownership requirement of
three-times-base-salary and have five years to achieve this level.
•Share ownership for this purpose includes direct and indirect ownership of common stock, including restricted stock and shares held through the lngredion 40I(k) plan, RSUs and phantom stock units held in the SERP. Stock options and unvested performance shares are not included in ownership for this purpose.
•Please note that unless or until the ownership requirement has been achieved, you are not permitted to sell shares of common stock other than to fund the payment of the exercise price of options or to fund the payment of taxes upon the exercise of options or vesting
of restricted stock units ("RSUs") or shares of restricted stock.
Confidentiality and Intellectual Property Rights and Non-Competition Agreements
•The terms and conditions of this offer remain contingent upon your agreement to the Restrictive Covenants contained in the form of Executive Severance Agreement provided by the Company, the terms and conditions of which
shall be deemed incorporated herein by reference, but which shall survive termination of your employment in accordance with its terms.
•This
letter of agreement and the Executive Severance Agreement shall constitute the entire agreement and understanding with respect to the matters described herein, and supersede any and all prior and/or contemporaneous agreements and understandings, oral or written.
•You agree that the benefits provided in this offer letter and the other benefits offered in the Executive Severance Agreement constitute sufficient consideration for your execution of these agreements.
Conditions
of Employment
As a condition of our offer of employment, as well as your continued employment by the Company, you must read, understand and abide by all applicable policies including:
1.the Executive Severance Agreement
2.the Ingredion Policies on Business Conduct.
All documents are provided with this letter,
and you will be asked to sign the Executive Severance Agreement and the Ingredion Policies on Business conduct on your first day as evidence of your agreement to abide by each, respectively. You agree
that the benefits provided in this offer letter, as well as your continued employment, constitute sufficient consideration for your execution of these agreements. In addition, your employment with Ingredion Incorporated is
contingent upon providing us with a complete copy of all agreements with your current and former employers regarding inventions, non-disclosure of confidential information, non-compete agreements, or any other employment restrictions that may impact your ability to perform the duties assigned
to you.
Pre-employment requirements
This offer and your continued employment are contingent upon the satisfactory completion of background and reference checks, passing a pre-employment drug screen and medical
evaluation (if applicable and where allowable by law), and the submission of proof of authorization to work in the United States. Once we receive written acceptance of this offer, we will begin our background verification and confirmation of the information you provided on the application form. You will not be able to begin work until we have satisfactorily completed the pre- employment requirements. Your current employer information will be verified as part of this process.
Employment eligibility verification
As a result of the Immigration Reform and Control Act of 1986, all employers are required by law to verify the work authorization status of each person they hire. Therefore, on your first day of work, you will be asked to complete the I-9 Employment Eligibility Verification form. As detailed on the enclosed Employment Eligibility
Verification List of Acceptable Documents, you must provide original documentation of your identity and work authorization within three days of your first day of work. The list of documents which are acceptable for this purpose are outlined in the Employment Eligibility Verification (I-9), which is attached for your reference.
Please
plan to bring these documents with you on your first day so we can complete this process in compliance with the federal rules.
Withholding requirements
All amounts paid or provided to you under this offer letter will be subject to any applicable income, payroll or other tax withholding requirements.
At-will employment
Nothing stated in this offer letter nor in any of our prior communications constitutes, or may be construed as, a commitment to, or contract
of or for, employment for any specific duration. Your employment with the Company will be “at will,” which means you
may leave the Company, or the
Company may require you to leave its employ, for any reason, at any time, except as otherwise provided by law. This at-will relationship will remain in effect throughout your employment with the Company and any of its successors, affiliates or related entities, unless it is modified by a specific, express, written employment contract which is signed by you and an authorized executive of the
Company.
Next steps
To accept this offer, please complete, sign, scan and return all documents as indicated in this letter via email to Matthew Conti, Vice President, Human Resources for Global Operating Excellence and Talent Acquisition at matthew.conti@ingredion.com.
If you have questions about the offer, or need to discuss a different start date, please contact Elizabeth Adefioye at 708-244-8712.
Any change in start date requested by you must be mutually agreed by the Company. This offer is valid and irrevocable until 04/24/20 and thereafter automatically expires.
Jeremy, we look forward
to your acceptance of this offer asap and the valuable contributions you will make at Ingredion.
Sincerely,
Elizabeth
Adefioye
Senior Vice President and Chief Human Resources Officer
Enclosures
a.Employment Eligibility Verification List of Acceptable Documents
b.Executive Severance Agreement
c.Ingredion Policies on Business Conduct
d.Bonus Reimbursement Agreement
Acceptance of employment
Please
indicate your acceptance of this offer by signing and dating below, completing the information on this and the following page, and returning to Matthew Conti at matthew.conti@ingredion.com.
I, Jeremy Xu, accept the terms and conditions set forth in this offer
of employment for the position of Chief Innovation Officer with Ingredion Incorporated
Signature: Date:
Relocation:
If your address on your first day of employment will be different from the one listed at the top of this letter, please indicate your correct address below:
Please complete this section with your acceptance. If you would prefer to complete this over the phone, please contact me directly. The information obtained will be kept confidential and may only be used in accordance with the provisions of applicable laws, executive orders, and regulations.
Social Security Number:
Birth
Date:
Please return the signed acceptance & personal data pages to Ingredion Global Talent Acquisition via email at: matthew.conti@ingredion.com.
Dates Referenced Herein and Documents Incorporated by Reference
